Diabetes Mellitus, Smoking Status, and Rate of Sputum Culture Conversion in Patients with Multidrug-Resistant Tuberculosis: A Cohort Study from the Country of Georgia

被引:36
作者
Magee, Matthew J. [1 ,2 ]
Kempker, Russell R. [3 ]
Kipiani, Maia [4 ]
Tukvadze, Nestani [4 ]
Howards, Penelope P. [1 ]
Narayan, K. M. Venkat [1 ,2 ]
Blumberg, Henry M. [1 ,2 ,3 ]
机构
[1] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
[4] Natl Ctr TB & Lung Dis, Tbilisi, Georgia
关键词
TREATMENT OUTCOMES; PREDICTORS; ASSOCIATION; IMPACT; RISK;
D O I
10.1371/journal.pone.0094890
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Diabetes mellitus (DM) is a risk factor for active tuberculosis (TB) but little is known about the effect of DM on culture conversion among patients with multidrug-resistant (MDR)-TB. The primary aim was to estimate the association between DM and rate of TB sputum culture conversion. A secondary objective was to estimate the association between DM and the risk of poor treatment outcomes among patients with MDR-TB. Materials and Methods: A cohort of all adult patients starting MDR-TB treatment in the country of Georgia between 20092011 was followed during second-line TB therapy. Cox proportional models were used to estimate the adjusted hazard rate of sputum culture conversion. Log-binomial regression models were used to estimate the cumulative risk of poor TB treatment outcome. Results: Among 1,366 patients with sputum culture conversion information, 966 (70.7%) had culture conversion and the median time to conversion was 68 days (interquartile range 50-120). The rate of conversion was similar among patients with MDR-TB and DM (adjusted hazard ratio [aHR] 0.95, 95% CI 0.71-1.28) compared to patients with MDR-TB only. The rate of culture conversion was significantly less in patients that currently smoked (aHR 0.82, 95% CI 0.71-0.95), had low body mass index (aHR 0.71, 95% CI 0.59-0.84), second-line resistance (aHR 0.56, 95% CI 0.43-0.73), lung cavities (aHR 0.70, 95% CI 0.59-0.83) and with disseminated TB (aHR 0.75, 95% CI 0.62-0.90). The cumulative risk of poor treatment outcome was also similar among TB patients with and without DM (adjusted risk ratio [aRR] 1.03, 95% CI 0.93-1.14). Conclusions: In adjusted analyses, DM did not impact culture conversion rates in a clinically meaningful way but smoking did.
引用
收藏
页数:9
相关论文
共 35 条
[1]  
[Anonymous], GLOB TUB REP 2013
[2]  
[Anonymous], 2013, Diabetes Atlas, V6th edn
[3]  
Aragon J., 2003, Phil J Internal Medicine, V41, P7
[4]   The impact of diabetes on tuberculosis treatment outcomes: A systematic review [J].
Baker, Meghan A. ;
Harries, Anthony D. ;
Jeon, Christie Y. ;
Hart, Jessica E. ;
Kapur, Anil ;
Loennroth, Knut ;
Ottmani, Salah-Eddine ;
Goonesekera, Sunali D. ;
Murray, Megan B. .
BMC MEDICINE, 2011, 9
[5]  
Chiang CY., 2013, Respirology
[6]   Tuberculosis and diabetes mellitus: convergence of two epidemics [J].
Dooley, Kelly E. ;
Chaisson, Richard E. .
LANCET INFECTIOUS DISEASES, 2009, 9 (12) :737-746
[7]   Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes [J].
Eugenia Jimenez-Corona, Maria ;
Pablo Cruz-Hervert, Luis ;
Garcia-Garcia, Lourdes ;
Ferreyra-Reyes, Leticia ;
Delgado-Sanchez, Guadalupe ;
Bobadilla-del-Valle, Miriam ;
Canizales-Quintero, Sergio ;
Ferreira-Guerrero, Elizabeth ;
Baez-Saldana, Renata ;
Tellez-Vazquez, Norma ;
Montero-Campos, Rogelio ;
Mongua-Rodriguez, Norma ;
Areli Martinez-Gamboa, Rosa ;
Sifuentes-Osornio, Jose ;
Ponce-de-Leon, Alfredo .
THORAX, 2013, 68 (03) :214-220
[8]   Type 2 diabetes and multidrug-resistant tuberculosis [J].
Fisher-Hoch, Susan P. ;
Whitney, Erin ;
Mccormick, Joseph B. ;
Crespo, Gonzalo ;
Smith, Brian ;
Rahbar, Mohammad H. ;
Restrepo, Blanca I. .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (11-12) :888-893
[9]   A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis [J].
Fitzpatrick, Christopher ;
Floyd, Katherine .
PHARMACOECONOMICS, 2012, 30 (01) :63-80
[10]   Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis [J].
Gandhi, Neel R. ;
Nunn, Paul ;
Dheda, Keertan ;
Schaaf, H. Simon ;
Zignol, Matteo ;
van Soolingen, Dick ;
Jensen, Paul ;
Bayona, Jaime .
LANCET, 2010, 375 (9728) :1830-1843